Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Completed NCT05091879

Preemptive Pharmacogenomics Testing Among Geriatric Patients

Conditions: Polypharmacy, Pharmacogenomic Testing

Sex: All

Ages: 65 Years – N/A

Healthy volunteers: No

Phase: NA

Enrollment: 66

Sponsor: Geisinger Clinic

Location: Geisinger Danville Pennsylvania

Summary

The primary goal of this study is to conduct pharmacogenomics testing (a type of DNA test) within an aging population and measure the impact of this test on medication selection, dosing, and costs of care.

Eligibility Criteria

Inclusion Criteria: * Follows at a Geisinger 65 Forward clinic location * Active prescriptions for 5 or more medications Exclusion Criteria: * Liver transplantation * Allogenic hematopoetic stem cell transplantation * Previously enrolled in the Electronic Medical Records and Genomics (eMERGE) pharmacogenomics cohort

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05091879). StuddyBuddy aggregates publicly available trial information.